Saccharomyces boulardii Administration Changes Gut Microbiota and Attenuates D-Galactosamine-Induced Liver Injury

Growing evidence has shown that gut microbiome is a key factor involved in liver health. Therefore, gut microbiota modulation with probiotic bacteria, such as Saccharomyces boulardii, constitutes a promising therapy for hepatosis. In this study, we aimed to investigate the protective effects of S. b...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Lei, Zhao, Xue-ke, Cheng, Ming-liang, Yang, Guo-zhen, Wang, Bi, Liu, Hua-juan, Hu, Ya-xin, Zhu, Li-li, Zhang, Shuai, Xiao, Zi-wen, Liu, Yong-mei, Zhang, Bao-fang, Mu, Mao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5430957/
https://www.ncbi.nlm.nih.gov/pubmed/28465509
http://dx.doi.org/10.1038/s41598-017-01271-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5430957/
https://www.ncbi.nlm.nih.gov/pubmed/28465509
http://dx.doi.org/10.1038/s41598-017-01271-9

Ejemplares similares